# A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence

> **NCT03656120** · PHASE2 · UNKNOWN · sponsor: **Wei Hao** · enrollment: 180 (estimated)

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** 0.2mg group
- **DRUG:** 0.5mg group
- **DRUG:** placebo control group

## Key facts

- **NCT ID:** NCT03656120
- **Lead sponsor:** Wei Hao
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-31
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2018-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03656120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03656120, "A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03656120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*